FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1579732520> ?p ?o ?g. }

• W1579732520 endingPage "148" @default.
• W1579732520 startingPage "139" @default.
• W1579732520 abstract "Today diabetic nephropathy is the leading course of end-stage renal disease; the incidence and prevalence of diabetic renal disease is still continuing to increase, particularly in the Western world. Despite improvements in diagnosis and treatment of diabetic nephropathy, only partial renal protection is reached with the current standard therapy regiments, including angiotensin-converting enzyme inhibitors and/or angiotensin receptor blockers. Against this background, it is of particular importance to learn more about the pathogenesis of diabetic nephropathy and to find new therapeutic approaches which alone or in combination with standard therapy have the potential to prevent or delay the progression of diabetic nephropathy, thus improving kidney and patient survival. Among others, endothelin (ET) receptor blockers have emerged as a potential therapeutic option that operates on the basis of physiological and pathophysiological effects of endothelin. Of note, the ET system was shown to be involved in hypertension and kidney disease, particularly proteinuric nephropathies, and there is good experimental data indicating a specific role of ET in the pathogenesis and progression of diabetic nephropathy. ET receptor blockers have been shown to be nephroprotective in animal models of type 1 and type 2 diabetes mellitus with the effects partly independent of blood pressure lowering. In patients with hypertension and diabetic nephropathies, the data is controversial and depends on the stage of the disease and the drug used. It was only recently that a large international clinical study (ASCEND) provided evidence for beneficial effects of ET antagonist treatment, i.e. reduction in proteinuria. Due to the premature termination of the study, however, hard endpoints like death could no longer be assessed. Another very recent randomized, double-blind, placebo-controlled trial of subjects with diabetic nephropathy also provided evidence for a specific antiproteinuric effect of the ET receptor antagonist atrasentan on top of an already existing blockade of the renin-angiotensin system. Thus, it appears currently of great scientific and clinical interest to shed some light on the role of the ET system and its blockade in diabetic nephropathy." @default.
• W1579732520 created "2016-06-24" @default.
• W1579732520 creator A5023997822 @default.
• W1579732520 creator A5051985691 @default.
• W1579732520 date "2011-01-01" @default.
• W1579732520 modified "2023-10-17" @default.
• W1579732520 title "Endothelin in Diabetic Renal Disease" @default.
• W1579732520 cites W147720950 @default.
• W1579732520 cites W1787623959 @default.
• W1579732520 cites W1946936285 @default.
• W1579732520 cites W1964302383 @default.
• W1579732520 cites W1966566822 @default.
• W1579732520 cites W1968318355 @default.
• W1579732520 cites W1981749140 @default.
• W1579732520 cites W1987935735 @default.
• W1579732520 cites W1990649196 @default.
• W1579732520 cites W2000148321 @default.
• W1579732520 cites W2012190892 @default.
• W1579732520 cites W2012577488 @default.
• W1579732520 cites W2025990454 @default.
• W1579732520 cites W2031654922 @default.
• W1579732520 cites W2043381088 @default.
• W1579732520 cites W2048097461 @default.
• W1579732520 cites W2049862929 @default.
• W1579732520 cites W2051964598 @default.
• W1579732520 cites W2054393454 @default.
• W1579732520 cites W2060688605 @default.
• W1579732520 cites W2074636215 @default.
• W1579732520 cites W2074692122 @default.
• W1579732520 cites W2075022360 @default.
• W1579732520 cites W2075068251 @default.
• W1579732520 cites W2076584321 @default.
• W1579732520 cites W2090688985 @default.
• W1579732520 cites W2093990370 @default.
• W1579732520 cites W2099754506 @default.
• W1579732520 cites W2100732774 @default.
• W1579732520 cites W2101457616 @default.
• W1579732520 cites W2105790451 @default.
• W1579732520 cites W2110143830 @default.
• W1579732520 cites W2117004007 @default.
• W1579732520 cites W2117741145 @default.
• W1579732520 cites W2121704189 @default.
• W1579732520 cites W2121767067 @default.
• W1579732520 cites W2133832496 @default.
• W1579732520 cites W2141108151 @default.
• W1579732520 cites W2141742095 @default.
• W1579732520 cites W2148798251 @default.
• W1579732520 cites W2156753852 @default.
• W1579732520 cites W2162804111 @default.
• W1579732520 cites W2165355441 @default.
• W1579732520 cites W2181604783 @default.
• W1579732520 cites W2195825270 @default.
• W1579732520 cites W2253899206 @default.
• W1579732520 cites W2286308763 @default.
• W1579732520 cites W2299045950 @default.
• W1579732520 cites W2311989966 @default.
• W1579732520 cites W2335383085 @default.
• W1579732520 cites W2416196100 @default.
• W1579732520 cites W2593197029 @default.
• W1579732520 doi "https://doi.org/10.1159/000328695" @default.
• W1579732520 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21893995" @default.
• W1579732520 hasPublicationYear "2011" @default.
• W1579732520 type Work @default.
• W1579732520 sameAs 1579732520 @default.
• W1579732520 citedByCount "25" @default.
• W1579732520 countsByYear W15797325202013 @default.
• W1579732520 countsByYear W15797325202014 @default.
• W1579732520 countsByYear W15797325202015 @default.
• W1579732520 countsByYear W15797325202016 @default.
• W1579732520 countsByYear W15797325202017 @default.
• W1579732520 countsByYear W15797325202018 @default.
• W1579732520 countsByYear W15797325202019 @default.
• W1579732520 countsByYear W15797325202020 @default.
• W1579732520 countsByYear W15797325202021 @default.
• W1579732520 countsByYear W15797325202022 @default.
• W1579732520 countsByYear W15797325202023 @default.
• W1579732520 crossrefType "book-chapter" @default.
• W1579732520 hasAuthorship W1579732520A5023997822 @default.
• W1579732520 hasAuthorship W1579732520A5051985691 @default.
• W1579732520 hasConcept C126322002 @default.
• W1579732520 hasConcept C134018914 @default.
• W1579732520 hasConcept C144980905 @default.
• W1579732520 hasConcept C170493617 @default.
• W1579732520 hasConcept C2778653478 @default.
• W1579732520 hasConcept C2779134260 @default.
• W1579732520 hasConcept C2779561371 @default.
• W1579732520 hasConcept C2779922275 @default.
• W1579732520 hasConcept C2780091579 @default.
• W1579732520 hasConcept C2780942790 @default.
• W1579732520 hasConcept C2781184683 @default.
• W1579732520 hasConcept C2909649922 @default.
• W1579732520 hasConcept C3019040382 @default.
• W1579732520 hasConcept C555293320 @default.
• W1579732520 hasConcept C71924100 @default.
• W1579732520 hasConceptScore W1579732520C126322002 @default.
• W1579732520 hasConceptScore W1579732520C134018914 @default.
• W1579732520 hasConceptScore W1579732520C144980905 @default.
• W1579732520 hasConceptScore W1579732520C170493617 @default.

• next